1. Home
  2. AAPG vs HBI Comparison

AAPG vs HBI Comparison

Compare AAPG & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • HBI
  • Stock Information
  • Founded
  • AAPG 2009
  • HBI 1901
  • Country
  • AAPG China
  • HBI United States
  • Employees
  • AAPG N/A
  • HBI N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • HBI Clothing/Shoe/Accessory Stores
  • Sector
  • AAPG Health Care
  • HBI Consumer Discretionary
  • Exchange
  • AAPG Nasdaq
  • HBI Nasdaq
  • Market Cap
  • AAPG 2.2B
  • HBI 1.9B
  • IPO Year
  • AAPG 2025
  • HBI 2006
  • Fundamental
  • Price
  • AAPG $37.38
  • HBI $4.43
  • Analyst Decision
  • AAPG Buy
  • HBI Hold
  • Analyst Count
  • AAPG 1
  • HBI 4
  • Target Price
  • AAPG N/A
  • HBI $5.75
  • AVG Volume (30 Days)
  • AAPG 14.3K
  • HBI 4.2M
  • Earning Date
  • AAPG 08-06-2025
  • HBI 08-07-2025
  • Dividend Yield
  • AAPG N/A
  • HBI N/A
  • EPS Growth
  • AAPG N/A
  • HBI N/A
  • EPS
  • AAPG N/A
  • HBI N/A
  • Revenue
  • AAPG $134,352,180.00
  • HBI $3,522,911,000.00
  • Revenue This Year
  • AAPG N/A
  • HBI $0.50
  • Revenue Next Year
  • AAPG $389.09
  • HBI N/A
  • P/E Ratio
  • AAPG N/A
  • HBI N/A
  • Revenue Growth
  • AAPG 341.77
  • HBI 0.65
  • 52 Week Low
  • AAPG $16.50
  • HBI $4.02
  • 52 Week High
  • AAPG $37.95
  • HBI $9.10
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • HBI 33.78
  • Support Level
  • AAPG N/A
  • HBI $4.54
  • Resistance Level
  • AAPG N/A
  • HBI $4.71
  • Average True Range (ATR)
  • AAPG 0.00
  • HBI 0.13
  • MACD
  • AAPG 0.00
  • HBI -0.05
  • Stochastic Oscillator
  • AAPG 0.00
  • HBI 5.63

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About HBI Hanesbrands Inc.

Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.

Share on Social Networks: